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Abstract
Transcatheter arterial chemoembolization (TACE) is a well-recognized procedure for management of hepatocel-
lular carcinoma. We present a 54-year-old man who presented with a periumbilical maculopapular skin rash 
that developed after an otherwise uneventful TACE procedure. A retrospective review of imaging was consistent 
with non-target embolization of the hepatic falciform artery (HFA). He was treated with oral non-steroidal anti-
inflammatory medication for 3 weeks with improvement, but had slight skin induration and an excoriated papule 
at 6-month follow-up. Non-target embolization of HFA is very rare, but clinicians and interventionalists should be 
aware of this complication, especially in patients predisposed to enlargement of HFA. 
Introduction
Hepatocellular cancer (HCC) is the most common primary malignant tumor of the liver, the fifth most common 
cancer worldwide, and the third most common cause of cancer-related death.1 Liver transplantation or surgical 
resection is the preferred treatment of HCC; however, many patients diagnosed with HCC are not surgical can-
didates. Transcatheter arterial chemoembolization (TACE) is central for management of intermediate BCLC-B 
stage HCC, as it has shown a survival benefit in these patients.1 A myriad of complications related to TACE has 
been described, and more systemic complications have been reported with conventional TACE than with TACE 
using drug-eluting beads (DEB-TACE).2,3 
Case Report
A 54-year-old man with a history of cirrhosis secondary to non-alcoholic steatohepatitis (NASH) presented to hepa-
tology clinic for management of cirrhosis. He complained of vague abdominal discomfort and subjective weakness 
for the prior 4 weeks. Abdominal examination showed mildly distended non-tender abdomen with normal bowel 
sounds. The laboratory work-up was unremarkable, with an alpha fetal protein level of 2.67 ng/mL. A triple-phase 
computed tomography (CT) showed a suspicious area of arterial enhancement in segment V of the liver (Figure 1). 
Triple-phase magnetic resonance imaging (MRI) confirmed a 2.6-cm arterially enhancing lesion in segment V that 
did not demonstrate portal venous phase washout, so the patient was managed with short-term imaging follow-up 
(Figure 1). A repeat triple-phase MRI obtained after 3 months showed interval increase in size of the lesion to 3.2 
cm (Figure 1). After discussion by a multidisciplinary tumor board, the patient was scheduled for TACE.
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Selective angiography of the middle hepatic artery showed a 
faint hypervascular focus corresponding to target lesion (Fig-
ure 2). The branch was subsequently embolized with 75 mg 
of doxorubicin loaded on 70-150 μm LC beads (BTG Interna-
tional, West Conshohocken, PA). The postembolization angio-
gram confirmed occlusion of the branch. The patient tolerat-
ed the procedure well and was discharged the next morning.
He returned 1 week later complaining of a worsening ‘red area’ 
on his belly that he noticed 3 days after the procedure. He de-
nied fever or pain. The initial examination showed a non-tender 
erythematous papular rash in the periumbilical area, predomi-
nantly on left side (Figure 3). A retrospective review of middle 
hepatic artery angiogram and cone beam CT obtained during 
the TACE procedure showed a patent hepatic falciform artery 
(HFA) that was not recognized during the procedure (Figure 
4). The clinical findings were consistent with non-target em-
bolization of the HFA. The patient was started on non-steroidal 
anti-inflammatory medication for 3 weeks. His rash partially 
cleared at his 3-week follow-up visit, but there was interval 
development of an approximately 1-cm ulcer with indurated 
margins (Figure 5). There was a nearly complete resolution of 
rash at his 6-month visit, but the ulcer persisted with dry es-
char, suggesting previous skin necrosis (Figure 5). The patient 
is currently doing well and is still on the liver transplant list.
Figure 1. (A) Arterial phase contrast-enhanced CT image showing a faint area of arterialization (arrow) in the segment V of liver adjacent to the GB fossa, ir-
regular liver outline, and splenomegaly (star). Arterial phase MRI images (B) at presentation and (C) at 3-month follow-up confirm the enlargement of a small 
arterially enhancing lesion in the right lobe (arrow).
Figure 2. Selective middle hepatic artery angiogram showing the hepatic fal-
ciform artery (arrows) with typical arc and caudal course. 
Figure 3. Irregularly coalescing erythematous papules and plaque around the 
left periumbilical area, visible 7 days after TACE. 
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Non-target embolization is a recognized complication of TACE. 
Common vessels prone to non-target embolization include the 
gastroduodenal artery, cystic artery, right gastric artery, retro-
duodenal artery, supraduodenal artery, accessory left gastric 
artery, and the HFA, which typically arises as a small termi-
nal branch of the left or middle hepatic artery that courses 
through the falciform ligament. It supplies the skin around 
the umbilicus and terminally communicates with branches of 
the superior and inferior epigastric arteries.4 The HFA can be 
recognized at angiography by its characteristic inferomedial 
diagonal course. Although the reported incidence of HFA dur-
ing angiography varies from 2–24.5%, very few cases of non-
target embolization to the HFA leading to abdominal wall rash 
or necrosis have been reported in the literature.3,5-9 The HFA 
may be relatively enlarged in patients with adhesions around 
the anterior abdominal wall due to prior laparotomy or in pa-
tients with stenosis/occlusion of the hepatic artery, theoretical-
ly making them more prone to such complications.9 Of note, 
neither of these factors was present in our patient.
Two factors that have been shown to cause a higher incidence 
of skin injury after transcatheter therapy are smaller size of 
embolization agents and use of continuous arterial injection.5,9 
The systemic complications are also less common with the 
use of DEB-TACE rather than conventional TACE.3 Typically, 
the biopsy of such a rash will show dermal sclerosis with fat 
necrosis and foreign body reaction. If large, these areas of fat 
necrosis can be demonstrable even on CT scan.7 In our case, 
skin biopsy was not performed because the rash presented 
immediately after TACE and retrospective review of the im-
ages was compatible with non-target embolization of the pat-
ent falciform artery. 
There is no consensus on the need of prophylactic emboliza-
tion of the HFA if noticed at angiography. A study involving 
127 patients, out of which 16 had patent HFA, showed that 
there is no need for prophylactic embolization of the HFA for 
prevention of skin rash prior to hepatic arterial chemoinfusion 
with or without subsequent embolization.10 Some reports have 
advocated prophylactic embolization with or without the use 
of ice packs on the upper abdomen for prevention of this rare 
complication.9,11 Due to its rarity, there is also no consensus 
regarding treatment of this complication. It is mostly treated 
with local warm compresses, non-steroidal anti-inflammatory 
drugs, and intralesional or oral steroids with or without anti-
histamines.5,7,9 Pentoxifylline, which is known to improve mi-
crocirculatory perfusion, has also been successfully used to 
treat the skin rash after TACE.12 
When the HFA is visualized on the angiogram, we propose 
that the operator place the tip of microcatheter distal to the 
origin of HFA to prevent this complication. If distal placement 
is not possible, it may be useful to perform prophylactic HFA 
embolization or place ice packs near umbilicus, especially in 
patients that have risk factors for relatively enlarged HFA.
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Figure 4. Immediate post procedure cone-beam CT image showing presence of 
hyperdense embolizing material (arrows) in the falciform ligament and coursing 
towards anterior abdominal wall consistent with course of the falciform artery.
Figure 5. (A) Partial clearance of the rash with interval formation of a 1 x 1 cm 
ulcer (arrow) with indurated margins approximately 5 cm from the umbilicus 
at 21-day follow-up. (B) Near complete interval resolution of erythematous 
papules and plaques but the ulcer (arrow) persisted with dry eschar suggest-
ing previous skin necrosis 6 months after TACE. 
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